Complete Response to Temozolomide in Metastatic Melanoma After Failure of 5 Lines of Treatment

被引：4
|
作者：
Magge, Tara [1 ]
Shaikh, Hira [2 ]
Chaudhary, Rekha [2 ]
机构：
[1] Univ Cincinnati, Dept Internal Med, Cincinnati, OH 45221 USA
[2] Univ Cincinnati, Dept Hematol & Oncol, Cincinnati, OH USA
来源：
AMERICAN JOURNAL OF THERAPEUTICS | 2022年 / 29卷 / 06期
关键词：
PHASE-III; CHEMOTHERAPY; SURVIVAL; INHIBITORS; NIVOLUMAB; RATES;
D O I：
10.1097/MJT.0000000000001186
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：E767 / E769
页数：3
相关论文
共 50 条
  • [1] Complete response of multiple melanoma brain metastases after treatment with temozolomide
    Dvorak, J
    Melichar, B
    Zizka, J
    Hadzi-Nikolov, D
    Petera, J
    ONKOLOGIE, 2004, 27 (02): : 171 - 174
  • [2] Complete response of cerebral metastasic melanoma after a combined treatment of radiotherapy and temozolomide
    Conill, C
    Puig, S
    Toscas, I
    Castel, T
    MEDICINA CLINICA, 2002, 119 (19): : 758 - 759
  • [3] Complete Remission of metastatic Melanoma under Therapy with Trametinib after Treatment Failure of Immunotherapy with Pembrolizumab
    Wahl, R.
    Ruebben, A.
    Amir, Y.
    Cacchi, C.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2019, 17 : 70 - 70
  • [4] Treatment of metastatic melanoma in the brain with temozolomide and thalidomide
    Hwu, WJ
    Raizer, J
    Panageas, KS
    Lis, E
    LANCET ONCOLOGY, 2001, 2 (10): : 634 - 635
  • [5] Temozolomide for the treatment of metastatic melanoma: A systematic review
    Quirt, Ian
    Verma, Shailendra
    Petrella, Teresa
    Bak, Kate
    Charette, Manya
    ONCOLOGIST, 2007, 12 (09): : 1114 - 1123
  • [6] Delayed but Complete Response following Oral Temozolomide Treatment in Melanoma Leptomeningeal Carcinomatosis
    Hottinger, Andreas F.
    Favet, Laurence
    Pache, Jean-Claude
    Martin, Jean-Baptiste
    Dietrich, Pierre-Yves
    CASE REPORTS IN ONCOLOGY, 2011, 4 (01): : 211 - 215
  • [7] Exceptional responses with sequential metronomic temozolomide after pembrolizumab failure in patients with metastatic melanoma
    Swami, Umang
    Monga, Varun
    Freesmeier, Michele
    Zhang, Weizhou
    Bossler, Aaron D.
    Zakharia, Yousef
    Milhem, Mohammed
    MELANOMA RESEARCH, 2019, 29 (06) : 643 - 647
  • [8] Toxicity of temozolomide with response modifiers in metastatic malignant melanoma
    Lorigan, P
    Danson, S
    Clamp, A
    Hodgetts, J
    Lomax, L
    Ashcroft, L
    Middleton, MR
    Thatcher, N
    BRITISH JOURNAL OF CANCER, 2002, 86 : S68 - S68
  • [9] Durable Complete Response After Discontinuation of Pembrolizumab in Patients With Metastatic Melanoma
    Robert, Caroline
    Ribas, Antoni
    Hamid, Omid
    Daud, Adil
    Wolchok, Jedd D.
    Joshua, Anthony M.
    Hwu, Wen-Jen
    Weber, Jeffrey S.
    Gangadhar, Tara C.
    Joseph, Richard W.
    Dronca, Roxana
    Patnaik, Amita
    Zarour, Hassane
    Kefford, Richard
    Hersey, Peter
    Zhang, Jin
    Anderson, James
    Diede, Scott J.
    Ebbinghaus, Scot
    Hodi, F. Stephen
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (17) : 1668 - +
  • [10] New approaches in the treatment of metastatic melanoma: Thalidomide and temozolomide
    Hwu, WJ
    ONCOLOGY-NEW YORK, 2000, 14 (12): : 25 - 28
12345